RecruitingNot ApplicableNCT03678194
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
Treating Depression on a Day-to-day Basis: Development of a Novel Clinical Tool for Physicians Based on a Smartphone Application, the SMART Project (Smartphones and Mood Disorders, an Application for Research and Treatment)
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Enrollment
200 participants
Start Date
Oct 14, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Testing and validating an e-health (smartphone application) approach to better understand the determinants of day-to-day symptomatology in depression, medication adherence, and treatment efficacy in the goal of maximizing patient care.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria6
- Age between 18 and 65 years;
- Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of depression assessed by the Structured Clinical Interview;
- Patients started their antidepressant treatment less than 5 days before inclusion;
- Patient treated in an outpatient setting;
- Patient informed of the diagnosis of his disease;
- Informed patient with written consent.
Exclusion Criteria5
- A current mental or psychiatric impairment or disease (schizophrenia, bipolar disorder) that required psychotropic medication or inpatient treatment on a psychiatric ward;
- A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features;
- Cognitive deficit and not thus being able to comprehend the informed consent and study procedure;
- Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy….);
- Non-comprehension of the French language
Interventions
DEVICESmartphone Support System
6 weeks smartphone application with daily evaluations
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03678194
Related Trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
NCT073265661 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Collection of Biological Samples From Patients With Rare Neurological Diseases
NCT046984211 location
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
NCT073648253 locations